Introduction to Reserpine’s Renewed Global Demand​ Reserpine, an alkaloid derived from Rauwolfia serpentina(Indian snakeroot), is experiencing a resurgence in global demand due to its cost-effectiveness in managing hypertension and mental health disorders. With over 1.28 billion adults worldwide affected by hypertension—particularly in low-resource regions—reserpine’s affordability (as low as $0.02–$0.05 per tablet) positions it as a critical therapeutic option. Emerging markets, such as Sub-Saharan Africa and Southeast Asia, rely on reserpine for public health programs, while developed regions are rediscovering its utility in combination therapies for treatment-resistant conditions. This article analyzes the key buyers, suppliers, regulatory landscapes, and procurement strategies shaping the global reserpine market . ​▲ Key Global Buyers and…